Brandon Burton
About Brandon Burton
Brandon Burton serves as the Associate Director of Research at Capricor Therapeutics, Inc., where he specializes in clinical research related to Cardiosphere derived cells. He holds a Bachelor of Applied Science in Mechanical Engineering and a Master of Science in Biomedical Engineering from the University of Florida.
Work at Capricor Therapeutics
Brandon Burton has served as the Associate Director of Research at Capricor Therapeutics, Inc. since 2012. In this role, he focuses on the clinical research of Cardiosphere derived cells (CDCs), which are a type of allogeneic human heart stem cells. His work involves overseeing manufacturing processes related to these stem cells, contributing to advancements in biomedical research and therapies. His tenure at Capricor Therapeutics spans over a decade, during which he has played a significant role in the company's research initiatives.
Education and Expertise
Brandon Burton holds a Bachelor of Applied Science (B.A.Sc.) in Mechanical Engineering from the University of Florida, where he studied from 2005 to 2009. He furthered his education by obtaining a Master of Science in Biomedical Engineering from the same institution, completing his studies from 2009 to 2011. His educational background equips him with a solid foundation in both mechanical and biomedical engineering, allowing him to design innovative solutions for complex engineering challenges.
Background
Brandon Burton began his career in engineering with internships at Northrop Grumman Corporation, where he worked as a Mechanical Systems Engineering Intern in 2006 and as a Mechanical Engineering Intern in 2007. He also gained research experience as a Graduate Research Assistant at the University of Florida from 2009 to 2012. This combination of industry and academic experience has contributed to his expertise in both mechanical and biomedical fields.
Achievements
Brandon Burton has demonstrated a strong capability in managing both industry and academic research projects. His involvement in the clinical research of Cardiosphere derived cells (CDCs) showcases his commitment to advancing biomedical engineering. His work in the manufacturing processes related to allogeneic human heart stem cells since 2012 highlights his contributions to innovative medical solutions.